William D. McClellan Jr. - 10 Jun 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
14 Jun 2021, 11:21:46 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 10 Jun 2021 Class A common stock 5,000 $146.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 4 equal installments on September 10, 2021, December 10, 2021, March 10, 2022, and June 10, 2022, subject to continued service through each vesting date.